These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effects of risperidone on the peripheral noradrenegic system in patients with schizophrenia: a comparison with clozapine and placebo. Elman I; Goldstein DS; Green AI; Eisenhofer G; Folio CJ; Holmes CS; Pickar D; Breier A Neuropsychopharmacology; 2002 Aug; 27(2):293-300. PubMed ID: 12093603 [TBL] [Abstract][Full Text] [Related]
3. The effect of clozapine on plasma norepinephrine: relationship to clinical efficacy. Breier A; Buchanan RW; Waltrip RW; Listwak S; Holmes C; Goldstein DS Neuropsychopharmacology; 1994 Feb; 10(1):1-7. PubMed ID: 8179790 [TBL] [Abstract][Full Text] [Related]
4. Different metabolism of norepinephrine and epinephrine by catechol-O-methyltransferase and monoamine oxidase in rats. Eisenhofer G; Finberg JP J Pharmacol Exp Ther; 1994 Mar; 268(3):1242-51. PubMed ID: 8138937 [TBL] [Abstract][Full Text] [Related]
5. Regional extraction of circulating norepinephrine, DOPA, and dihydroxyphenylglycol in humans. Goldstein DS; Cannon RO; Quyyumi A; Chang P; Duncan M; Brush JE; Eisenhofer G J Auton Nerv Syst; 1991 Jun; 34(1):17-35. PubMed ID: 1940014 [TBL] [Abstract][Full Text] [Related]
6. Neuronal uptake, metabolism, and release of tritium-labeled norepinephrine during assessment of its plasma kinetics. Eisenhofer G; Esler MD; Goldstein DS; Kopin IJ Am J Physiol; 1991 Oct; 261(4 Pt 1):E505-15. PubMed ID: 1928342 [TBL] [Abstract][Full Text] [Related]
7. New approaches to evaluate sympathoadrenal system activity in experiments on earth and in space. Kvetnansky R; Noskov VB; Blazicek P; Macho L; Grigoriev AI; Goldstein DS; Kopin IJ Acta Astronaut; 1994 Oct; 34():243-54. PubMed ID: 11540743 [TBL] [Abstract][Full Text] [Related]
9. Abnormal plasma monoamine metabolism in schizophrenia and its correlation with clinical responses to risperidone treatment. Cai HL; Fang PF; Li HD; Zhang XH; Hu L; Yang W; Ye HS Psychiatry Res; 2011 Jul; 188(2):197-202. PubMed ID: 21146875 [TBL] [Abstract][Full Text] [Related]
10. Simultaneous measurement of plasma and brain extracellular fluid concentrations of catechols after yohimbine administration in rats. Szemeredi K; Komoly S; Kopin IJ; Bagdy G; Keiser HR; Goldstein DS Brain Res; 1991 Feb; 542(1):8-14. PubMed ID: 2054662 [TBL] [Abstract][Full Text] [Related]
11. Plasma dihydroxyphenylglycol and the intraneuronal disposition of norepinephrine in humans. Goldstein DS; Eisenhofer G; Stull R; Folio CJ; Keiser HR; Kopin IJ J Clin Invest; 1988 Jan; 81(1):213-20. PubMed ID: 3335637 [TBL] [Abstract][Full Text] [Related]
12. Sources and significance of plasma levels of catechols and their metabolites in humans. Goldstein DS; Eisenhofer G; Kopin IJ J Pharmacol Exp Ther; 2003 Jun; 305(3):800-11. PubMed ID: 12649306 [TBL] [Abstract][Full Text] [Related]
13. Influence of clozapine on platelet serotonin, monoamine oxidase and plasma serotonin levels. Ertugrul A; Ucar G; Basar K; Demir B; Yabanoglu S; Ulug B Psychiatry Res; 2007 Jan; 149(1-3):49-57. PubMed ID: 17157920 [TBL] [Abstract][Full Text] [Related]
14. Diminished suicidal and aggressive behavior, high plasma norepinephrine levels, and serum triglyceride levels in chronic neuroleptic-resistant schizophrenic patients maintained on clozapine. Spivak B; Roitman S; Vered Y; Mester R; Graff E; Talmon Y; Guy N; Gonen N; Weizman A Clin Neuropharmacol; 1998; 21(4):245-50. PubMed ID: 9704166 [TBL] [Abstract][Full Text] [Related]
15. Lipid status, anti-oxidant enzyme defence and haemoglobin content in the blood of long-term clozapine-treated schizophrenic patients. Miljevic C; Nikolic M; Nikolic-Kokic A; Jones DR; Niketic V; Lecic-Tosevski D; Spasic MB Prog Neuropsychopharmacol Biol Psychiatry; 2010 Mar; 34(2):303-7. PubMed ID: 19962416 [TBL] [Abstract][Full Text] [Related]
16. Patterns of cerebrospinal fluid catechols support increased central noradrenergic responsiveness in aging and Alzheimer's disease. Raskind MA; Peskind ER; Holmes C; Goldstein DS Biol Psychiatry; 1999 Sep; 46(6):756-65. PubMed ID: 10494443 [TBL] [Abstract][Full Text] [Related]
17. Plasma dihydroxyphenylglycol (DHPG) in the in vivo assessment of human neuronal norepinephrine metabolism. Izzo JL; Thompson DA; Horwitz D Life Sci; 1985 Sep; 37(11):1033-8. PubMed ID: 4033349 [TBL] [Abstract][Full Text] [Related]
18. Norepinephrine metabolism in neuron: dissociation between 3,4-dihydroxyphenylglycol and 3,4-dihydroxymandelic acid pathways. Dong WX; Ni XL Acta Pharmacol Sin; 2002 Jan; 23(1):59-65. PubMed ID: 11860739 [TBL] [Abstract][Full Text] [Related]
19. Differential inhibition of neuronal and extraneuronal monoamine oxidase. Eisenhofer G; Lenders JW; Harvey-White J; Ernst M; Zametkin A; Murphy DL; Kopin IJ Neuropsychopharmacology; 1996 Sep; 15(3):296-301. PubMed ID: 8873113 [TBL] [Abstract][Full Text] [Related]
20. Effects of clozapine and typical antipsychotic drugs on plasma 5-HT turnover and impulsivity in patients with schizophrenia: a cross-sectional study. Dursun SM; Szemis A; Andrews H; Whitaker P; Reveley MA J Psychiatry Neurosci; 2000 Sep; 25(4):347-52. PubMed ID: 11022399 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]